Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exit

21st Feb 2022 11:33

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Bivictrix Therapeutics PLC, up 10% at 27.00 pence, 12-month range 17.00p-35.00p. The drug development company strengthens patent portfolio with filing of four new patents. The patent applications focus on novel cancer-specific antigen fingerprints.

----------

AIM - LOSERS

----------

Synairgen PLC, down 79% at 35.47p, 12-month range 10.00p-223.80p. Shares in drug discovery and biotechnology company hit 12-month low as it says late-stage trial of SNG001 did not meet primary or key secondary efficacy endpoints. Antiviral therapy SNG001 is a proposed treatment for people suffering from chronic obstructive pulmonary disease.

----------

Morses Club PLC, down 61% at 16.20p, 12-month range 13.51p-95.00p. Shares in home-collected credit provider hit 12-month low after issuing a profit warning and announcing immediate departure of Chief Executive Officer Paul Smith. Morses says surge in customer complaints against its doorstep-lending unit HCC "in recent days" meant that profit would be 20% to 30% lower than analyst expectations. Smith has left his role as CEO and stepped down from the board with immediate effect days after selling stock without telling the company in advance. Gary Marshall, chief operating officer, has been appointed as CEO.

----------

ADVFN PLC, down 16% at 58.50p, 12-month range 23.00p-94.99p. The financial information provider posts drop in first half profit. For six months ended December 31, profit falls to GBP202,000 from GBP264,000 year before on revenue of GBP4.22 million, down from GBP4.23 million.

----------

By Arvind Bhunjun; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.


Related Shares:

MCL.LBVX.LSynairgenADVFN
FTSE 100 Latest
Value8,809.74
Change53.53